GeneDx Holdings Corp vs Advanced Drainage Systems Inc — how do they compare? GeneDx Holdings Corp trades at $61.92 (market cap $1.80B), while Advanced Drainage Systems Inc trades at $143.04 (market cap $10.96B). The key difference: Advanced Drainage Systems Inc is far larger — about 6.1× GeneDx Holdings Corp's market cap, and Advanced Drainage Systems Inc pays a 0.56% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| WGS | WMS | |
|---|---|---|
Market Cap | $1.80B | $10.96B |
Sector | Technology | Industrials |
52-Week High | $167.51 | $175.38 |
52-Week Low | $34.51 | $110.99 |
Enterprise Value | $1.80B | $12.53B |
Dividend Yield | — | 0.56% |
Signals from Pluang's Aura AI — not financial advice
GeneDx Holdings (WGS) trades at $60.65, down 4.46% today, amid a bearish technical signal and multiple class-action lawsuits alleging securities fraud. The stock shows weak fundamentals with a negative net income margin of -17.58% and ROE of -30.42%, though it beat EPS estimates in two of the last three quarters. Revenue grew to $427.54M in 2025 but profitability remains a challenge, with a high EV/EBITDA of 161.17 indicating stretched valuation relative to earnings.
Despite a 90.9% analyst buy rating and a $75.40 consensus price target, significant risks from litigation and persistent losses cloud the outlook. The stock faces near-term pressure from legal overhangs, while operational cash flow turned negative in 2026. Investors should weigh high analyst optimism against substantial fundamental and legal headwinds before considering a position.
WMS (Advanced Drainage Systems) trades at $138.74, down 5.97% on the day, with a bearish technical signal. The company shows solid fundamentals with a 13.98% net income margin and consistent earnings beats in recent quarters, though 2025 revenue was flat at $2.90B. Recent news includes a dividend increase and upcoming Q1 FY2027 results on August 6, 2026.
The stock presents a mixed outlook. Strong profitability and a consensus price target of $184.43 suggest upside potential, but near-term headwinds include a bearish technical setup and projected earnings decline in 2026. Key risks are execution on investments and competitive pressures in the water management sector.
Trailing returns across standard periods
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →Advanced Drainage Systems Inc is engaged in designing, manufacturing, and marketing thermoplastic corrugated pipe and related water management products in North and South America, and Europe. The company's operating segment includes Pipe
Read more on WMS →